Cyr-Depauw Chanèle, Northey Jason J, Tabariès Sébastien, Annis Matthew G, Dong Zhifeng, Cory Sean, Hallett Michael, Rennhack Jonathan P, Andrechek Eran R, Siegel Peter M
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada Department of Biochemistry, McGill University, Montréal, Québec, Canada.
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada Department of Medicine, McGill University, Montréal, Québec, Canada.
Mol Cell Biol. 2016 May 2;36(10):1509-25. doi: 10.1128/MCB.00600-15. Print 2016 May 15.
ShcA is an important mediator of ErbB2- and transforming growth factor β (TGF-β)-induced breast cancer cell migration, invasion, and metastasis. We show that in the context of reduced ShcA levels, the bone morphogenetic protein (BMP) antagonist chordin-like 1 (Chrdl1) is upregulated in numerous breast cancer cells following TGF-β stimulation. BMPs have emerged as important modulators of breast cancer aggressiveness, and we have investigated the ability of Chrdl1 to block BMP-induced increases in breast cancer cell migration and invasion. Breast cancer-derived conditioned medium containing elevated concentrations of endogenous Chrdl1, as well as medium containing recombinant Chrdl1, suppresses BMP4-induced signaling in multiple breast cancer cell lines. Live-cell migration assays reveal that BMP4 induces breast cancer migration, which is effectively blocked by Chrdl1. We demonstrate that BMP4 also stimulated breast cancer cell invasion and matrix degradation, in part, through enhanced metalloproteinase 2 (MMP2) and MMP9 activity that is antagonized by Chrdl1. Finally, high Chrdl1 expression was associated with better clinical outcomes in patients with breast cancer. Together, our data reveal that Chrdl1 acts as a negative regulator of malignant breast cancer phenotypes through inhibition of BMP signaling.
ShcA是ErbB2和转化生长因子β(TGF-β)诱导的乳腺癌细胞迁移、侵袭和转移的重要介质。我们发现,在ShcA水平降低的情况下,骨形态发生蛋白(BMP)拮抗剂类脊索蛋白1(Chrdl1)在TGF-β刺激后的众多乳腺癌细胞中上调。BMP已成为乳腺癌侵袭性的重要调节因子,我们研究了Chrdl1阻断BMP诱导的乳腺癌细胞迁移和侵袭增加的能力。含有升高浓度内源性Chrdl1的乳腺癌条件培养基以及含有重组Chrdl1的培养基,均可抑制多种乳腺癌细胞系中BMP4诱导的信号传导。活细胞迁移试验表明,BMP4诱导乳腺癌细胞迁移,而Chrdl1可有效阻断这一过程。我们证明,BMP4还可刺激乳腺癌细胞侵袭和基质降解,部分是通过增强金属蛋白酶2(MMP2)和MMP9的活性,而Chrdl1可拮抗这种活性。最后,Chrdl1高表达与乳腺癌患者更好的临床结局相关。总之,我们的数据表明,Chrdl1通过抑制BMP信号传导,作为恶性乳腺癌表型的负调节因子。